Status:
WITHDRAWN
Genetic Identification (ID) of Segmental Dysplastic Nevi
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Segmental Dysplastic Nevi
Eligibility:
All Genders
18+ years
Brief Summary
The investigators' goal is to identify the mutation in the gene that is responsible for the development of segmental dysplastic nevi. To identify the gene the investigators may use a candidate gene ap...
Detailed Description
Dysplastic (atypical) melanocytic (DMN) nevi have been identified as being potential precursors of melanoma and markers for patients at risk of developing primary melanoma1. In addition, having an inc...
Eligibility Criteria
Inclusion
- Patient with a positive history of segmental dysplastic nevi
Exclusion
- None
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00955578
Start Date
August 1 2009
End Date
March 1 2010
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Capital Heatlh
Halifax, Nova Scotia, Canada, B3H1V7